Clinician decision making in peripheral intravenous cannulation in emergency settings
Peripheral intravenous cannulation (PIVC) is a vital part of modern medicine, however the use of cannulas has become prolific, with many never used. The patient risks that are associated with PIVC are well documented, including pain and infections, which can be severe and lead to death. Reducing the rate of idle PIVCs (inserted but never used) may reduce the overall rate of risks, side-effects and infections associated with PIVC, but may also lead to patients who require PIVC not receiving one. This study aims to describe: I) the proportion of PIVCs placed that do not get used within 24 hours…
Principal Investigator:
Mr Hugo Evison
Amount Awarded: $34,794
Institution: Queensland Ambulance Service
READ MORE
READ MORE
The Crystalloid versus Albumin in tThe Resuscitation of Emergency Department Patients with Septic Shock (CARESS) trial inflammatory marker pilot study.
The aim of this study was to determine whether 4% albumin solution is superior to saline for fluid resuscitation of patients presenting to the emergency department with septic shock.
Principal Investigator:
Dr Julian Williams
Amount Awarded: $41,270
Institution: Royal Brisbane & Women's Hospital
READ MORE
READ MORE
Capacity Building Grant – third year: The Prince Charles Hospital
This grant provides a 'third-year' extension of funding as part of a 2011 EMF Capacity Building grant awarded to The Prince Charles Hospital Emergency Department. With the Capacity Building grant, the Department has engaged in more than 20 research projects. The majority involve significant input from the Hospital's emergency clinicians, who are working in collaboration with other Queensland and interstate emergency department and/or academic institutions such as CSIRO.
Principal Investigator:
Dr Frances Kinnear
Amount Awarded: $20,000
Institution: The Prince Charles Hospital
READ MORE
READ MORE
Implementation of Nasal High Flow: A Remote Context
In this study, the clinician-researchers are exploring whether nasal high flow (NHF) therapy can be safely and effectively used to improve health outcomes for infants with bronchiolitis in isolated remote communities, in particular for remote Indigenous Australians who have a higher incidence rate of bronchiolitis than non-Indigenous Australians. There is a desire by clinicians to implement NHF in remote areas, but this should undergo similar scientific scrutiny as previous published data. NHF is a respiratory support system that provides support for people with respiratory conditions and is applied by high flow oxygen through nasal prongs. The therapy can avoid an…
Principal Investigator:
Mrs Sally West
Amount Awarded: $50,000
Institution: James Cook University
READ MORE
READ MORE
Paediatric Reduction in Emergency Cannula Accidental REmoval Trial – PRECARE trial
The aim of this study is to evaluate securement devices for peripheral intravenous catheters (PIVC) in the paediatric ED to determine which method is most effective for reducing PIVC failure, associated costs, acceptability and patient distress. Infants and children depend on PIVCs for the provision of medical therapy within the emergency department and during hospitalisation. However, PIVC insertion and management is challenging and more than 25% of devices fail. PIVC failure is costly for both the patient and healthcare organisation. Failure may require the child to undergo traumatic reinsertion procedures, delay important medical treatment and prolong length of hospital stay.…
Principal Investigator:
Ms Brooke Charters
Amount Awarded: $96,034
Institution: Logan Hospital
READ MORE
READ MORE